SARS-CoV-2 in immunocompromised individuals
Article
[키워드] adaptive
anti-CD20
antiviral immune response
B cell
Cancer
clearance
Combination
COVID-19
COVID-19 pandemic
Critical
Hematologic malignancy
Immunity
Immunocompromised
immunocompromised individual
immunologically
immunosuppressive
IMPROVE
increased risk
individual
Infection
Inflammation
information
limit
morbidity and mortality
populations
provided
SARS-CoV-2
T cell
therapy
Treatment
treatment strategy
underlying conditions
understanding
vaccination
vaccination.
viral infection
virus
[DOI] 10.1016/j.immuni.2022.09.006 PMC 바로가기
[DOI] 10.1016/j.immuni.2022.09.006 PMC 바로가기